2 completed, 2 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Unknown 2 |
Follow Albinism: new trials by email Literature Review of Albinism trials Research Report on Albinism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients ReCell, Full surface CO2 laser 200 mJ, Full surface CO2 laser 150 mJ - Segmental Vitiligo, Piebaldism | Phase 4 | Completed | Netherlands Institute for Pigment Disorders | 10 | 2015-05-01 | 2017-04-04 |
| Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study Nilotinib - Chronic Myelogenous Leukemia (CML), Metastatic Gastrointestinal Stromal Tumors (GIST) | Phase 4 | Completed | Novartis Pharmaceuticals | 57 | 2013-03-29 | 2024-02-08 |
| Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients ReCell epidermal cell suspension grafting, CO2 laser abrasion + UV-therapy - Piebaldism, Segmental Vitiligo | Phase 4 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 10 | 2012-06-01 | 2013-08-05 |
| Punchgrafting Techniques for Vitiligo punchgrafting - Non-segmental Vitiligo, Segmental Vitiligo | Phase 4 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 35 | 2011-06-01 | 2011-06-21 |
Piebaldism (4) · Vitiligo (2) · Gastrointestinal Stromal Tumors (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Amino Acid Metabolism, Inborn Errors (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Eye Diseases, Hereditary (4) · Genetic Diseases, Inborn (4) · Hypopigmentation (4) · Metabolic Diseases (4) · Metabolism, Inborn Errors (4) · Nutritional and Metabolic Diseases (4) · Pigmentation Disorders (4) · Skin Diseases (4) · Skin Diseases, Genetic (4) · Skin and Connective Tissue Diseases (4) · Bone Marrow Diseases (1) · Chronic Disease (1)
nilotinib (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Netherlands Institute for Pigment Disorders (1) · Novartis Pharmaceuticals (1)
Netherlands (4) · Austria (1) · Canada (1) · France (1) · Hong Kong (1) · Hungary (1) · Israel (1) · Italy (1) · Russia (1) · Singapore (1) · Slovakia (1) · South Korea (1) · Spain (1) · Sweden (1) · United Kingdom (1)
Albert Wolkerstorfer, MD, PhD (1) · Menno A. De Rie, MD, PhD (1)